Trump’s Hair and Health: What the Gaps Reveal

People have started noticing changes in the former president’s appearance after his latest medical checkup. A slightly puffier face, a voice that cracks sometimes, and moments when his words are harder to hear have all raised eyebrows. His once bright blond hair is turning gray, and the comb‑over that covered a thinning crown looks less full than before. Social media users have pointed out that the hair change tells its own story. A new medical report has made the public focus more on what’s happening at the top of his head than on the fine print. While doctors warn against diagnosing anyone from photos alone, a recent disclosure has given critics new material to discuss. The Washington Post revealed that finasteride – the drug used by many men to slow hair loss – is missing from Trump’s latest health record. The medication, sold as Propecia, had appeared in earlier reports and was confirmed by several doctors over the years.Finasteride was first linked to Trump in 2017 after questions about his low PSA levels. His longtime doctor said he was taking the drug, and it kept showing up in official documents until it vanished after his reelection. The newest report lists cholesterol drugs and aspirin but no mention of finasteride, leading some to wonder if he stopped taking it. The White House said only clinically relevant medications were disclosed, a statement that raised concerns among medical ethicists. Experts argue that hair alone does not prove whether the drug is being used, but the timing of its disappearance from records and the visible thinning have fueled speculation. Meanwhile, Trump continues to tout his “perfect health, ” even as plans for a new White House medical wing stir questions about why such facilities would be needed. Observers note that the changes in his appearance – from swollen ankles to a pink scalp exposed when the wind blows his hair away – add layers to an ongoing debate. Whether the missing finasteride is linked to the thinning hair or simply a reporting omission remains unclear, but the silence from the White House only deepens curiosity.